Nasdaq:US$18.03 (+0.20) | HKEX:HK$28.80 (+0.60) | AIM:£2.85 (+0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2011

AACR 2011: Savolitinib (HMPL-504) against subcutaneous xenograft and orthotopic brain tumor models